Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus

scientific article published on 13 December 2019

Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12944-019-1169-2
P932PMC publication ID6909521
P698PubMed publication ID31836012

P50authorAhmed Tijani BawahQ88070052
P2093author name stringSalifu Nanga
Huseini Alidu
Mohammed Mustapha Seini
Albert Abaka-Yawason
P2860cites workInterpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiersQ21563322
Diagnosis and Classification of Diabetes MellitusQ22255454
Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epitheliumQ24541303
Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysisQ26827131
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistanceQ29012156
Leptin and the regulation of body weight in mammalsQ29615976
Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesisQ30884235
The role of leptin in glucose homeostasisQ33609782
Adiposity and hyperleptinemia during the first trimester among pregnant women with preeclampsiaQ33826224
Gestational diabetes.Q33844982
Glucose intolerance and cardiometabolic risk in adolescents exposed to maternal gestational diabetes: a 15-year follow-up studyQ33873237
Lipid profile in consecutive pregnanciesQ33998122
Human epicardial adipose tissue is a source of inflammatory mediatorsQ34272633
Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosisQ35204725
Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from ChinaQ35965157
The placenta cytokine network and inflammatory signalsQ36293812
Risk factors for gestational diabetes mellitus: implications for the application of screening guidelinesQ37836950
Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysisQ38328566
Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD studyQ39561309
Maternal hyperlipidemia in pregnancy.Q40757993
Pregnancy as a risk factor for obesity: lessons from the Stockholm Pregnancy and Weight Development StudyQ40958707
Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetesQ43633853
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humansQ44730563
Regulation of fasted blood glucose by resistinQ44771734
High resistin and interleukin-6 levels are associated with gestational diabetes mellitus.Q46029233
Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.Q46137148
Components of metabolic syndrome and their impact on fetal growth in women with gestational diabetes mellitus.Q46291283
Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancyQ46710236
Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition.Q46784161
Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitusQ47651004
Severe hypertriglyceridemia-induced pancreatitis during pregnancyQ48707252
Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes.Q50775001
Depot-related gene expression in human subcutaneous and omental adipocytes.Q50868029
Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.Q51476483
Chronic stretching of amniotic epithelial cells increases pre-B cell colony-enhancing factor (PBEF/visfatin) expression and protects them from apoptosis.Q51964310
Partial leptin deficiency and human adiposity.Q55035506
Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individualsQ57607812
Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnanciesQ60455193
Fetal overnutrition in polynesian pregnancies and in gestational diabetes may lead to dysregulation of the adipoinsular axis in offspringQ74660903
Decreased plasma visfatin concentrations in women with gestational diabetes mellitusQ79824119
Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitusQ83420259
Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomesQ86095834
P433issue1
P921main subjectgestational diabetesQ126691
P304page(s)221
P577publication date2019-12-13
P1433published inLipids in Health and DiseaseQ15756695
P1476titleLeptin, resistin and visfatin as useful predictors of gestational diabetes mellitus
P478volume18

Reverse relations

cites work (P2860)
Q89842569Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis
Q97884153Serum concentration of asprosin in new-onset type 2 diabetes
Q90340504Whole transcriptome expression profiles in placenta samples from women with gestational diabetes mellitus

Search more.